Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) Sees Large Decline in Short Interest

Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) saw a significant decline in short interest in December. As of December 15th, there was short interest totalling 58,400 shares, a decline of 23.9% from the November 30th total of 76,700 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Surgical Science Sweden AB (publ) Price Performance

OTCMKTS:SUSRF opened at $14.53 on Friday. The stock has a 50-day simple moving average of $12.37 and a two-hundred day simple moving average of $12.23. Surgical Science Sweden AB has a 52-week low of $11.30 and a 52-week high of $14.30.

Surgical Science Sweden AB (publ) Company Profile

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases.